Niagen Bioscience, Inc. (NAGE)
3.17
+0.06
(+1.93%)
USD |
NASDAQ |
Sep 04, 16:00
3.16
-0.01
(-0.32%)
After-Hours: 20:00
Niagen Bioscience Shareholders Equity (Quarterly) : 82.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 82.53M |
| March 31, 2026 | 82.33M |
| December 31, 2025 | 76.53M |
| September 30, 2025 | 70.68M |
| June 30, 2025 | 64.20M |
| March 31, 2025 | 55.34M |
| December 31, 2024 | 46.09M |
| September 30, 2024 | 34.37M |
| June 30, 2024 | 30.72M |
| March 31, 2024 | 28.95M |
| December 31, 2023 | 28.46M |
| September 30, 2023 | 27.31M |
| June 30, 2023 | 27.15M |
| March 31, 2023 | 28.02M |
| December 31, 2022 | 28.67M |
| September 30, 2022 | 21.02M |
| June 30, 2022 | 20.78M |
| March 31, 2022 | 25.88M |
| December 31, 2021 | 31.73M |
| September 30, 2021 | 35.45M |
| June 30, 2021 | 42.14M |
| March 31, 2021 | 43.83M |
| December 31, 2020 | 16.42M |
| September 30, 2020 | 19.49M |
| June 30, 2020 | 21.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.55M |
| December 31, 2019 | 20.44M |
| September 30, 2019 | 27.14M |
| June 30, 2019 | 15.14M |
| March 31, 2019 | 20.98M |
| December 31, 2018 | 27.18M |
| September 30, 2018 | 33.40M |
| June 30, 2018 | 40.50M |
| March 31, 2018 | 46.66M |
| December 31, 2017 | 53.83M |
| September 30, 2017 | 33.74M |
| June 30, 2017 | 25.72M |
| March 31, 2017 | 9.372M |
| December 31, 2016 | 9.974M |
| September 30, 2016 | 11.86M |
| June 30, 2016 | 12.45M |
| March 31, 2016 | 6.428M |
| December 31, 2015 | 5.275M |
| September 30, 2015 | 4.336M |
| June 30, 2015 | 3.896M |
| March 31, 2015 | 3.689M |
| December 31, 2014 | 3.998M |
| September 30, 2014 | 4.503M |
| June 30, 2014 | 4.318M |
| March 31, 2014 | 4.794M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cyanotech Corp. | 7.985M |
| Mannatech, Inc. | -4.97M |
| Natural Alternatives International, Inc. | 63.11M |
| USANA Health Sciences, Inc. | 526.31M |
| Nature's Sunshine Products, Inc. | 169.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 106.59M |
| Total Liabilities (Quarterly) | 24.06M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 6.497 |
| Net Debt Paydown Yield | 0.09% |